BC
BLUE

BIT Capital’s bluebird bio BLUE Stock Holding History

BIT Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,058
Closed -$245K – 104
2023
Q3 		$245K Hold
4,058
– – 0.03% 81
2023
Q2 		$261K Buy
4,058
+2,308
+132% +$169K 0.02% 105
2023
Q1 		$110K Buy
1,750
+700
+67% +$79.9K 0.02% 123
2022
Q4 		$144K Sell
1,050
-2,000
-66% -$282K 0.03% 120
2022
Q3 		$348K Sell
3,050
-528
-15% -$59.7K 0.07% 101
2022
Q2 		$328K Buy
+3,578
New +$277K 0.04% 84

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

BIT Capital's BLUE Position: Q4 2023 in Review

BIT Capital sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 4,058 shares — an estimated $245K sold.

BIT Capital first reported a position in BLUE in Q2 2022 and held it in 6 quarters. The position peaked at $348K in Q3 2022. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • BIT Capital reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • BIT Capital sold 4,058 bluebird bio shares in Q4 2023, an estimated $245K.
  • BIT Capital first reported a position in bluebird bio in Q2 2022 and held it in 6 quarters.
  • BIT Capital's bluebird bio position peaked at $348K in Q3 2022.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on BIT Capital's 13F filing for Q4 2023, filed 12 Feb 2025.